A share price of Replimune Group Inc [REPL] is currently trading at $10.21, down -2.30%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The REPL shares have gain 23.01% over the last week, with a monthly amount glided 143.68%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Replimune Group Inc [NASDAQ: REPL] stock has seen the most recent analyst activity on October 27, 2025, when H.C. Wainwright upgraded its rating to a Buy but kept the price target unchanged to $12 for it. Previously, Wedbush upgraded its rating to Outperform on October 20, 2025, and kept the price target unchanged to $18. On October 20, 2025, upgrade upgraded it’s rating to Overweight but maintained its price target of $13 on the stock. Leerink Partners upgraded its rating to a Outperform but stick to its price target of $13 on October 20, 2025. JP Morgan upgraded its rating to a Neutral. JP Morgan downgraded its rating to Underweight for this stock on September 19, 2025. In a note dated July 30, 2025, Cantor Fitzgerald upgraded an Overweight rating on this stock.
Replimune Group Inc experienced fluctuations in its stock price throughout the past year between $2.68 and $17.00. Currently, Wall Street analysts expect the stock to reach $15 within the next 12 months. Replimune Group Inc [NASDAQ: REPL] shares were valued at $10.21 at the most recent close of the market. An investor can expect a potential return of 46.91% based on the average REPL price forecast.
Analyzing the REPL fundamentals
Gross Profit Margin for this corporation currently stands at -1.92% with Operating Profit Margin at -200.19%, Pretax Profit Margin comes in at -190.05%, and Net Profit Margin reading is -190.37%. To continue investigating profitability, this company’s Return on Assets is posted at -0.6, Equity is -0.69 and Total Capital is -0.72. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.23.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 9.91 points at the first support level, and at 9.61 for the second support level. However, for the 1st resistance point, the stock is sitting at 10.56, and for the 2nd resistance point, it is at 10.91.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Replimune Group Inc [NASDAQ:REPL] is 6.94. Further, the Quick Ratio stands at 6.94, while the Cash Ratio is 1.63.
Transactions by insiders
Recent insider trading involved Hill Emily Luisa, Chief Financial Officer, that happened on Aug 15 ’25 when 9154.0 shares were sold. Director, Astley-Sparke Philip completed a deal on May 20 ’25 to sell 32279.0 shares. Meanwhile, Chief Medical Officer Xynos Konstantinos sold 7952.0 shares on May 20 ’25.
